Literature DB >> 32954580

Pulmonary rehabilitation in COVID-19 pandemic era: The need for a revised approach.

Ajay Prashad Gautam1, Ross Arena2,3, Snehil Dixit1,4, Audrey Borghi-Silva5,6.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32954580      PMCID: PMC7536923          DOI: 10.1111/resp.13946

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.175


× No keyword cloud information.
The coronavirus disease 2019 (COVID‐19) pandemic is affecting millions of people worldwide with no current signs of abatement; manifestation of illness in those infected with the virus varies widely, from asymptomatic requiring no treatment to very severe complications requiring mechanical ventilation support. Initially, the virus was thought to primarily effect the pulmonary system alone, but later it was recognized that the virus can impact multiple organ systems also. Nevertheless, those who are physically fit and possess a healthy living phenotype are less severely affected by the disease than those with pre‐existing co‐morbid conditions and hence having less morbidity and mortality. The recovery rate of COVID‐19 is improving with time due to better insight of the disease and available treatment options and hence, the number of survivors is increasing. During the recovery period, it has been reported that even patients with symptoms as a result of the viral infection continue to experience dyspnoea, chest pain and fatigue; these symptoms have been shown to persist for weeks following acute recovery. In patients recovering from a more severe manifestation of the viral infection, severe morbidity and low quality of life persist. Pulmonary rehabilitation (PR) has the potential to play a vital role in the recovery of patients infected with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). However, the traditional approach to PR is not conducive to the healthcare environment in the COVID‐19 era. In this context, the approach must be modified from the perspective of both the rehabilitation programme employed as well as a focus on minimizing the possibility of viral spread by transferring the patients to the government or community‐designated isolation centres. In this pandemic era, the multidisciplinary role by members is crucial with primary role of the members being to re‐enforce the PR plan for COVID‐19 and provide awareness, education and support whenever required. Telerehabilitation is an important component of PR in this environment as it allows access to patients who would benefit while minimizing human‐to‐human contact. During face‐to‐face treatment, healthcare professionals should employ techniques that require minimal manual handling of patients, such as remote‐controlled mechanical tilting beds, mechanical assisted limb exercisers and closed‐circuit suctioning. In the immediate post‐recovery period, patients must remain in isolation for at least 2 weeks before enrolling for supervised PR programme. During this isolation phase, patients should be advised to perform low‐to‐moderate intensity exercises as per individual capabilities or using self‐perceived exertion scales which can be easily administered from remote centres. Following the self‐isolation phase, exercise testing and prescription need to be assessed under strict protocols to minimize viral spread; properly ventilated rooms and sanitization of rehabilitation settings are essential components. Proper nutritional counselling and psychological rehabilitation are also important components of PR that should be included. Table 1 lists a proposed modified approach to PR for the COVID‐19 era. The authors of this correspondence hope that readers will find this proposed approach to be of value when considering how to alter the approach to PR.
Table 1

Proposed phase wise PR protocol depending on the severity of symptoms

(1) Asymptomatic patients (no or minimal V/Q mismatch)—Telerehabilitation
Goal: Prevention of developing comorbidities and early recovery
Improvement of immunity Aerobic exercises, yoga and nutritional care
Improve lung compliance Deep breathing, intercostal expansion and yoga
Respiratory muscle conditioning IMT at moderate to high intensity using MIP to set intensity
Skeletal muscle conditioning Aerobic and resistance training targeting larger muscles group. Train at moderate to high intensity using RPE and 10 RM for setting intensity

Oxygen supplementation will not be required and need for telemonitoring (vitals) will be minimal unless other pre‐existing co‐morbid conditions

Activities log and telemonitoring can be done for improving compliance

(2) Symptomatic patients not requiring mechanical ventilation (minimal to moderate V/Q mismatch)—Telerehabilitation

Goal: Prevention of comorbidities and early recovery
Improvement of immunity Aerobic exercises, yoga and nutritional care
Improve lung compliance Deep breathing and yoga
Improvement of alveolar ventilation/oxygenation Postural drainage and autogenic drainage/active cycle of breathing techniques
Respiratory muscle conditioning IMT at moderate intensity
Skeletal muscle conditioning Aerobic and resistance training at moderate intensity targeting larger muscle group

Oxygen supplementation may be required during exercise training and need for telemonitoring (SpO2 by pulse oximetry) will be mandatory whether other pre‐existing co‐morbid conditions are present

Activities pacing training and self‐symptoms monitoring must be incorporated
Caution: No active exercise if fever and weakness are worsening

(3) Symptomatic patients requiring mechanical ventilation (moderate to severe V/Q mismatch)—ICU rehabilitation protocols

Goal: Improve pulmonary ventilation and prevent deconditioning
Improvement of alveolar ventilation/oxygenation

Pneumonia: Airway clearance techniques—modified postural drainage regimen, suctioning—closed loop suctioning will be better than open suctioning

ARDS: Prone positioning and frequent change in positions and appropriate mechanical ventilation strategies

Improvement of immunity Nutritional care (protein‐rich diet, zinc and vitamins)—enteral/parenteral route
Improve lung compliance Ventilatory setting with appropriate PEEP adjusted
Weaning from mechanical ventilation

T‐piece trials

IMT (moderate intensity) through endotracheal /tracheostomy tube as tolerable

Skeletal muscle conditioning

Active/active assisted/passive exercises, cycle ergometry and electric muscle stimulation at the bedside may be considered approaches

Early ambulation strategies as tolerated once vital signs stabilize

Neuromuscular electrical stimulation

Need for telemonitoring (SpO2 by pulse oximetry) will be mandatory during all the ICU rehabilitation phase whether other pre‐existing co‐morbid conditions are present

N.B. (1) In addition, regular psychological counselling and rehabilitation should also go side by side in each phase of rehabilitation in all the affected patients (2) Special precautions must also be taken if pre‐existing co‐morbid conditions are also present
(4) Post recovery period—(A) Supervised training, (B) Home/self‐monitored training

(A) Supervised training—Individualized exercise testing and prescription

Goal: Improve cardiopulmonary and physical conditioning
Improvement of alveolar ventilation/oxygenation

If pulmonary fibrosis is present, perform training with oxygen supplementation as needed

If secretions are present, perform airway clearance techniques

Improvement of immunity Aerobic exercises, yoga and nutritional care
Improve lung compliance Deep breathing, intercostal expansion and yoga
Respiratory muscle conditioning IMT at moderate to high intensity, using MIP to set intensity
Skeletal muscle conditioning Aerobic and resistance training targeting larger muscles group at moderate to high intensity, using RPE and 10 RM for setting intensity
N.B. As patients will be non‐contagious, rehabilitation still requires separate settings than the other patients. Proper precautionary and safety measures must be followed at rehabilitation settings as prescribed by regulatory bodies for prevention of COVID‐19 spread. Make patients learn rehabilitation exercises and self‐monitoring of vitals
(B) Home/self‐monitored training
Goals and means are same as of supervised training
Telerehabilitation can be used to improve compliance of the PR

General: For non‐infected people in the community

Goal: Staying fit and prevention of comorbidities due to long‐term home stay
Interventions: Aerobics, resistance and flexibility exercises such as meditation and yoga
Emphasize on activities easily done at home—aerobic dancing, leisure activities—skipping, cycling, stepping, stair climbing, etc. if treadmill is not available

COVID‐19, coronavirus disease 2019; ICU, intensive care unit; IMT, inspiratory muscle training; MIP, maximal inspiratory pressure; PEEP, positive end‐expiratory pressure; PR, pulmonary rehabilitation; RM, repetition maximum; RPE, rate of perceived exertion; V/Q, ventilation/perfusion.

Proposed phase wise PR protocol depending on the severity of symptoms Oxygen supplementation will not be required and need for telemonitoring (vitals) will be minimal unless other pre‐existing co‐morbid conditions (2) Symptomatic patients not requiring mechanical ventilation (minimal to moderate V/Q mismatch)—Telerehabilitation Oxygen supplementation may be required during exercise training and need for telemonitoring (SpO2 by pulse oximetry) will be mandatory whether other pre‐existing co‐morbid conditions are present (3) Symptomatic patients requiring mechanical ventilation (moderate to severe V/Q mismatch)—ICU rehabilitation protocols Pneumonia: Airway clearance techniques—modified postural drainage regimen, suctioning—closed loop suctioning will be better than open suctioning ARDS: Prone positioning and frequent change in positions and appropriate mechanical ventilation strategies T‐piece trials IMT (moderate intensity) through endotracheal /tracheostomy tube as tolerable Active/active assisted/passive exercises, cycle ergometry and electric muscle stimulation at the bedside may be considered approaches Early ambulation strategies as tolerated once vital signs stabilize Neuromuscular electrical stimulation Need for telemonitoring (SpO2 by pulse oximetry) will be mandatory during all the ICU rehabilitation phase whether other pre‐existing co‐morbid conditions are present (A) Supervised training—Individualized exercise testing and prescription If pulmonary fibrosis is present, perform training with oxygen supplementation as needed If secretions are present, perform airway clearance techniques General: For non‐infected people in the community COVID‐19, coronavirus disease 2019; ICU, intensive care unit; IMT, inspiratory muscle training; MIP, maximal inspiratory pressure; PEEP, positive end‐expiratory pressure; PR, pulmonary rehabilitation; RM, repetition maximum; RPE, rate of perceived exertion; V/Q, ventilation/perfusion.
  4 in total

1.  Physiotherapy management for COVID-19 in the acute hospital setting: clinical practice recommendations.

Authors:  Peter Thomas; Claire Baldwin; Bernie Bissett; Ianthe Boden; Rik Gosselink; Catherine L Granger; Carol Hodgson; Alice Ym Jones; Michelle E Kho; Rachael Moses; George Ntoumenopoulos; Selina M Parry; Shane Patman; Lisa van der Lee
Journal:  J Physiother       Date:  2020-03-30       Impact factor: 7.000

2.  The Stanford Hall consensus statement for post-COVID-19 rehabilitation.

Authors:  Robert M Barker-Davies; Oliver O'Sullivan; Kahawalage Pumi Prathima Senaratne; Polly Baker; Mark Cranley; Shreshth Dharm-Datta; Henrietta Ellis; Duncan Goodall; Michael Gough; Sarah Lewis; Jonathan Norman; Theodora Papadopoulou; David Roscoe; Daniel Sherwood; Philippa Turner; Tammy Walker; Alan Mistlin; Rhodri Phillip; Alastair M Nicol; Alexander N Bennett; Sardar Bahadur
Journal:  Br J Sports Med       Date:  2020-05-31       Impact factor: 13.800

Review 3.  The global path forward - Healthy Living for Pandemic Event Protection (HL - PIVOT).

Authors:  Ross Arena; Carl J Lavie
Journal:  Prog Cardiovasc Dis       Date:  2020-05-30       Impact factor: 8.194

4.  Pulmonary rehabilitation in COVID-19 pandemic era: The need for a revised approach.

Authors:  Ajay Prashad Gautam; Ross Arena; Snehil Dixit; Audrey Borghi-Silva
Journal:  Respirology       Date:  2020-09-21       Impact factor: 6.175

  4 in total
  7 in total

Review 1.  Long COVID-19: The Need for an Interdisciplinary Approach.

Authors:  Isabel Rodriguez-Sanchez; Leocadio Rodriguez-Mañas; Olga Laosa
Journal:  Clin Geriatr Med       Date:  2022-03-21       Impact factor: 3.529

2.  The benefits of pulmonary rehabilitation in patients with COVID-19.

Authors:  Zhen-Feng He; Nan-Shan Zhong; Wei-Jie Guan
Journal:  ERJ Open Res       Date:  2021-05-31

3.  Importance of functional capacity assessment and physical exercise during and after hospitalization in COVID-19 patients: revisiting pulmonary rehabilitation.

Authors:  Audrey Borghi-Silva; Alaparthi Gopal Krishna; Adriana Sanches Garcia-Araujo
Journal:  J Bras Pneumol       Date:  2021-09-06       Impact factor: 2.624

4.  Knowledge, Attitude, and Practice among Physical Therapists toward COVID-19 in the Kingdom of Saudi Arabia-A Cross-Sectional Study.

Authors:  Adel Alshahrani; Ajay Prashad Gautam; Faisal Asiri; Irshad Ahmad; Mastour Saeed Alshahrani; Ravi Shankar Reddy; Mutasim D Alharbi; Khalid Alkhathami; Hosam Alzahrani; Yasir S Alshehri; Raee Alqhtani
Journal:  Healthcare (Basel)       Date:  2022-01-05

Review 5.  Providing rehabilitation to patients recovering from COVID-19: A scoping review.

Authors:  Marina B Wasilewski; Stephanie R Cimino; Kristina M Kokorelias; Robert Simpson; Sander L Hitzig; Lawrence Robinson
Journal:  PM R       Date:  2021-10-07       Impact factor: 2.218

6.  Pulmonary rehabilitation in COVID-19 pandemic era: The need for a revised approach.

Authors:  Ajay Prashad Gautam; Ross Arena; Snehil Dixit; Audrey Borghi-Silva
Journal:  Respirology       Date:  2020-09-21       Impact factor: 6.175

Review 7.  Post-COVID-19 acute sarcopenia: physiopathology and management.

Authors:  Karolina Piotrowicz; Jerzy Gąsowski; Jean-Pierre Michel; Nicola Veronese
Journal:  Aging Clin Exp Res       Date:  2021-07-30       Impact factor: 3.636

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.